Are we at the bottom, page-168

Charts, dont forget,
with MYX having some 85% of the oral contraceptive market, E4 will cannibalize some of our existing sales.
MITHRA'S price action of late is a really good indicator of the future profits of this gamechanger.
Im not aware of the profit margins regarding E4,one would think they'd be a lot higher than a generic oral contraceptive.
And being a world first definitely has it's advantages,(even with patent protection for 20yrs)
With FDA approval and an effective launch campaign i can genuinely see a $1-$1.50 as a realistic price re-rate,also not
forgetting a re-inclusion into ASX200 at $1.00 and knocking on the door of minimum market cap for asx100 at $1.50.


if ALL the volume on thursday were short coverings,that still leaves at least 10mill that have to exit as of 4 days ago.
I cant wait for the market to re-open and watch them burn.Better still,an announcement of a trading halt,pending price sensitive announcement.
Even RICHARDS would have to admit its price sensitive.....hahahaha.